Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2003-12-5
pubmed:abstractText
Anaplastic oligodendrogliomas (AO) are uncommon primary brain tumors whose natural history, prognosis, and optimal management are not yet fully understood. However, they are associated with a better prognosis and response to multimodality therapy based on specific molecular changes. In this multicenter retrospective study, we analyzed the clinical characteristics of patients with AO to identify prognostic factors that influence time to progression (TTP) and survival.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0030-2414
pubmed:author
pubmed:copyrightInfo
Copyright 2003 S. Karger AG, Basel
pubmed:issnType
Print
pubmed:volume
65
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
259-66
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:14657600-Adolescent, pubmed-meshheading:14657600-Adult, pubmed-meshheading:14657600-Age Distribution, pubmed-meshheading:14657600-Aged, pubmed-meshheading:14657600-Brain Neoplasms, pubmed-meshheading:14657600-Combined Modality Therapy, pubmed-meshheading:14657600-Disease Progression, pubmed-meshheading:14657600-Disease-Free Survival, pubmed-meshheading:14657600-Female, pubmed-meshheading:14657600-Humans, pubmed-meshheading:14657600-Karnofsky Performance Status, pubmed-meshheading:14657600-Male, pubmed-meshheading:14657600-Middle Aged, pubmed-meshheading:14657600-Neoplasm Recurrence, Local, pubmed-meshheading:14657600-Oligodendroglioma, pubmed-meshheading:14657600-Prognosis, pubmed-meshheading:14657600-Retrospective Studies, pubmed-meshheading:14657600-Sex Distribution, pubmed-meshheading:14657600-Survival Rate, pubmed-meshheading:14657600-Tumor Markers, Biological
pubmed:year
2003
pubmed:articleTitle
Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival.
pubmed:affiliation
University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. vpuduval@mdanderson.org
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Multicenter Study